Lucintel’s latest market report analyzed that tangential flow filtration provides attractive opportunities in pharmaceutical & biotechnology companies, contract research organizations & contract manufacturing organizations (CMOs & CROs), and academic institutes & research laboratories. The tangential flow filtration market is expected to reach $2.7 billion by 2028 with a CAGR of 11.4%. In this market, membrane filters is the largest segment by product, whereas pharmaceutical and biotechnology company is largest by end use industry.
Download Brochure of this report by clicking on https://www.lucintel.com/tangential-flow-filtration-market.aspx
Based on product, the tangential flow filtration market is segmented into single use systems, reusable systems, membrane films, and filtration accessories. The membrane filters segment accounted for the largest share of the market in 2023 and is expected to register the highest CAGR during the forecast period, due to increasing demand in the pharmaceutical industry as membrane filters offer accuracy, higher flow rate, less filtration time, and minimized cross-contamination.
Browse in-depth TOC on “Tangential Flow Filtration Market”
100 – Figures/Tables
150 – Pages
The Tangential Flow Filtration Market is marked by the presence of several big and small players. Some of the prominent players offering tangential flow filtration include Danaher Corporation, Merck Millipore, Sartorius Stedim Biotech, Parker Hannifin Corporation, GE Healthcare, Alfa Laval, Novasep, Pendotech, and Spectrum Laboratories.
Request Sample Report:
https://www.lucintel.com/tangential-flow-filtration-market.aspx
This unique research report will enable you to make confident business decisions in this globally competitive marketplace. For a detailed table of contents, contact Lucintel at +1-972-636-5056 or click on this link helpdesk@lucintel.com.
About Lucintel
Lucintel, the premier global management consulting and market research firm, creates winning strategies for growth. It offers market assessments, competitive analysis, opportunity analysis, growth consulting, M&A, and due diligence services to executives and key decision-makers in a variety of industries. For further information, visit www.lucintel.com.
Roy Almaguer
Lucintel
Dallas, Texas, USA
Email: roy.almaguer@lucintel.com
Tel. 972.636.5056
Roy Almaguer Lucintel Dallas, Texas, USA Email: roy.almaguer@lucintel.com Tel. 972.636.5056
Tags:
Reportedtimes, Extended Distribution, iCN Internal Distribution, Research Newswire, English